References
- Mosley D. H., Schatz I. J., Breneman G. M., Keyes J. V. V. Long term anticoagulant therapy. JAMA 1963; 186: 914–916
- Coon W. W., Willis P. W. Haemorrhagic complications of anticoagulant therapy. Arch. Intern. Med. 1974; 133: 386–392
- Loeliger E. A. The optimal therapeutic range in oral anticoagulation. Thromb. Haemost. 1979; 42: 1141–1152
- Starr H. I., Lam-Po-Tang P. R. L.C. Australasian Reference Thromboplastin–The need for a reference thromboplastin. Aust. J. Med. Technol. 1978; 9: 47–54
- Starr H. I., Rhoades P., Lam-Po-Tang P. R. L.C., Archer G. T. Prothrombin times: an evaluation of four thromboplastins and four machines. Pathology 1980; 12: 567–574
- Dacie J. V., Lewis S. M. Practical Haematology, 5th edition. Churchill Livingstone, Edinburgh 1975
- Loeliger E. A., Van Halem-Visser L. P. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH Collaborative Study on prothrombin time standardization. Thromb. Haemost. 1979; 42: 1115–1127
- Sise M. S., Lavelle S. M., Adamis D., Becker R. Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants. N. Engl. J. Med. 1958; 259: 266–271
- Kazmier F. J., Spitwell J. A., Thompson J. J., Owen C. A. Effect of oral anticoagulants on factors VII, IX, X and II. Arch. Intern. Med. 1965; 115: 667–673